Amneal Expands Broad Injectables Portfolio With The Addition of Six New Product Launches
Amneal's Q2 2024 injectable product launches:
Product launch | Dosage form | ASHP drug shortage | |
1 | PEMRYDI RTU® | Vial | No |
2 | Atropine sulfate | Prefilled syringe | Yes |
3 | Docetaxel | Injection | Yes |
4 | Foscarnet | IV bag | No |
5 | Methylprednisolone acetate | Multi-dose vial | Yes |
6 | Calcium gluconate | Vial | No |